BioSpace News Archive

Global Blood Therapeutics, Inc. announced updates across several of its development programs in sickle cell disease.

Bone allografts are being widely used in dentistry. The preparation and processing for safe use and effective graft material needs an experience clinicians who can handle and place the allografts in the right position.

A Fact.MR survey on Europe diet pills market offers detailed analysis on the key growth drivers and restraints affecting demand.

argenx announced that it will host a conference call and audio webcast on Thursday, July 29, 2021 at 2:30 p.m. CET to discuss its half year 2021 financial results and provide a second quarter business update.

Anocca AB, a leader in unlocking the potential of T-cell immunotherapy to deliver transformative therapeutics for cancer, announced the closing of a USD 47 million Series B financing to further advance the company’s industrialised cellular biology platform and progress its pipeline of TCR-T cellular therapies into Phase I/IIa clinical trials.

Quest Diagnostics Incorporated, the world’s leading provider of diagnostic information services, announced financial results for the second quarter ended June 30, 2021.

Merck and Eisai Inc. announced that the FDA has approved the combination of KEYTRUDA, Merck’s anti-PD-1 therapy, plus LENVIMA, the orally available multiple receptor tyrosine kinase inhibitor discovered by Eisai, for the treatment of patients with advanced endometrial carcinoma that is not microsatellite instability-high or mismatch repair deficient, who have disease progression following prior systemic therapy in any setting and are not candidates for curative surgery or radiation.

VBL Therapeutics announced the planned elevation of Marc Kozin as chairman of the company’s board of directors.

Nabriva Therapeutics plc announced that it will report its second quarter financial results along with recent company highlights after the close of the U.S. financial markets on Thursday, August 5, 2021.

The increasing cases of various cancer types have created numerous research and development activities.